Stationary alpha thalassemia can be treated with supportive therapy, medication, and blood transfusion. Resting type α-thalassemia is caused by abnormalities in the α-pearl protein gene, and is caused by the absence of only one α-pearl protein peptide chain. 1. Supportive treatment: if the patient has no symptoms and does not affect normal development, no treatment can be done and regular review is recommended. 2. Drug treatment: for patients with low resistance, appropriate supplementation of vitamin C, folic acid, vitamin B₁₂ and so on. 3. Blood transfusion therapy: for more serious patients, red blood cells can be transfused under the guidance of the doctor if necessary. If the diagnosis is confirmed as stationary alpha thalassemia, it is recommended to carry out standardized treatment in order to reduce the adverse effects of the disease. All the above medications should be used under doctor’s guidance, avoid self-medication.